Hydrocortisone / pramoxine topical Pregnancy and Breastfeeding Warnings
Hydrocortisone / pramoxine topical is also known as: Analpram E, Analpram-HC, Enzone, Epifoam, HC Pram, HC Pramoxine, Hydropram, Novacort, Pramcort, Pramosone, Pramosone E, Procort, Proctofoam HC, Rectocort HC, Zone-A, Zone-A Forte, Zypram
Hydrocortisone / pramoxine topical Pregnancy Warnings
Hydrocortisone-pramoxine topical has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence that the more potent corticosteroids have been teratogenic after dermal application. Corticosteroids are generally teratogenic in laboratory animals when administered systemically at relatively low dosage levels. There are no controlled data in human pregnancy. Hydrocortisone-pramoxine topical should only be given during pregnancy when benefits outweigh risks. Drugs of this class should not be used extensively on pregnant patients, in large amounts, or for prolonged periods of time.
Hydrocortisone / pramoxine topical Breastfeeding Warnings
It is not known whether topical administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in breast milk. Systemically administered corticosteroids are secreted into breast milk in quantities not likely to have a harmful effect on the infant. Nevertheless, caution should be exercised when topical corticosteroids are administered to a nursing woman.
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.